Sphygmomanometer Market Size, Share, Growth, and Industry Analysis, By Type (Mercury,Aneroid,Digital), By Application (Hospital,Clinic,Other), Regional Insights and Forecast to 2035

Sphygmomanometer Market Overview

Global Sphygmomanometer Market valued at USD 3828.79 Million in 2026, projected to reach USD 8114.75 Million by 2035, growing at a CAGR of 8.7%.

The Sphygmomanometer Market is a vital segment of the medical device industry, with more than 146 million units in active use worldwide by 2024. Out of these, digital sphygmomanometers account for 64%, aneroid types for 23%, and mercury-based devices for 13%.

The Sphygmomanometer Market Report highlights that 82% of large healthcare institutions have modernized their blood pressure monitoring equipment.

In the United States, the Sphygmomanometer Market Size includes over 45 million active units in 2024, making it one of the largest markets globally with a 31% share of global installations. Among these, digital models dominate with 68% share, aneroid devices hold 20%, and mercury models account for 12%.

Hospitals represent 56% of the total U.S. usage, clinics account for 30%, and home care and others represent 14%. More than 2,000 healthcare institutions have shifted from mercury-based devices to digital units, and 7,500 outpatient clinics use automated BP monitoring systems as part of patient care improvements.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising prevalence of hypertension influences 54% of global healthcare facilities, while 68% of hospitals invest in digital devices, and 63% of clinical facilities upgrade BP monitoring equipment.
• Major Market Restraint: High cost impacts 46% of small clinics, availability issues affect 25% of rural facilities, and 19% of global buyers prefer low-cost manual alternatives.
• Emerging Trends: Digital technology accounts for 64% share, automated wireless monitoring devices for 15%, and 11% of global installations now include mobile application integration.
• Regional Leadership: North America holds 39% global share, Europe has 28%, Asia-Pacific has 25%, while Middle East & Africa represent 8% of total units in 2024.
• Competitive Landscape: Top five manufacturers collectively hold 61% of global share, with the top two capturing 32%, and 39% share distributed among over 25 companies.
• Market Segmentation: Hospitals represent 51% installations, clinics 36%, and others 13%, with digital devices at 64%, aneroid 23%, and mercury 13%.
• Recent Development: In 2024, 12 million new sphygmomanometers were installed globally, including 7.6 million digital devices, 3.1 million aneroid units, and 1.3 million mercury-based units.

Sphygmomanometer Market Latest Trends

The Sphygmomanometer Market Trends demonstrate the global shift from mercury-based units to digital and automated devices. Out of 146 million units in use globally, 64% are digital, 23% are aneroid, and 13% are mercury devices. Digital models saw an installation growth of 7.6 million units in 2024, particularly in hospitals and large clinics. In North America, 39% of global installations are present, followed by Europe with 28%, Asia-Pacific with 25%, and Middle East & Africa with 8%.

Sphygmomanometer Market Dynamics

The Sphygmomanometer Market Dynamics section presents a comprehensive analysis of the factors influencing market performance globally. It examines how the 146 million active sphygmomanometers worldwide, including 93 million digital, 34 million aneroid, and 19 million mercury units, are driven by increasing hypertension cases affecting 1.28 billion people. This section discusses market drivers such as the 51% hospital usage share and 12 million new units added in 2024, restraints including 46% of small clinics limited by cost and 25% rural supply challenges, opportunities in 19 million home-care units with 26% wireless-enabled adoption, and challenges such as 61% market concentration among top companies.

DRIVER

"Rising global prevalence of hypertension and demand for accurate monitoring devices."

Hypertension affects more than 1.28 billion people globally, which has prompted 68% of hospitals and 63% of clinics to invest in advanced sphygmomanometers. As of 2024, there are 146 million active sphygmomanometers globally, and 12 million new units were added just in 2024. Hospitals contribute 51% of installations, and digital models represent 64% of global usage. The Sphygmomanometer Industry Analysis shows that automated and digital models are preferred by 82% of modern healthcare institutions to ensure real-time blood pressure tracking and reduce manual errors.

RESTRAINT

"High costs of digital devices and slow replacement in rural areas."

High cost of digital models impacts 46% of small-scale clinics, and 25% of rural healthcare institutions face availability issues. Manual mercury-based devices, which still represent 13% of the total market, remain common in rural and underdeveloped regions due to affordability. Even though 3.1 million aneroid units were installed in 2024, small clinics report difficulty upgrading to automated systems. The Sphygmomanometer Market Outlook reflects a slower shift from manual to automated models in low-resource regions.

OPPORTUNITY

"Increasing demand for home healthcare monitoring devices."

The global share of home healthcare use rose from 10% in 2021 to 13% in 2024, accounting for 19 million units in 2024. Digital models make up 75% of home healthcare devices, and 26% of these models include wireless connectivity. Demand for compact, portable, and app-enabled BP monitors increased by 15% in 2024, opening new channels for manufacturers to innovate. This trend also presents an opportunity for companies focusing on direct-to-consumer markets and telemedicine platforms.

CHALLENGE

"Standardization issues and market fragmentation."

Top five companies hold 61% share, leaving 39% fragmented among more than 25 small manufacturers. Lack of standardization in calibration processes leads to 14% of devices inaccuracy reports, affecting patient trust. Additionally, 22% of healthcare facilities report inadequate training for digital device usage, causing implementation barriers. The Sphygmomanometer Market Growth faces challenges in harmonizing international standards and ensuring device accuracy across all regions.

Sphygmomanometer Market Segmentation

The Sphygmomanometer Market Segmentation covers type and application. By type, 64% of installations are digital, 23% are aneroid, and 13% are mercury devices. By application, 51% of devices are used in hospitals, 36% in clinics, and 13% in other applications, including home healthcare and research. The Sphygmomanometer Market Research Report indicates that in 2024 alone, 12 million units were added globally. Digital models dominated with 7.6 million new units, while aneroid and mercury devices accounted for 3.1 million and 1.3 million units, respectively. The segmentation analysis underlines the dominance of digital devices in institutional settings.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Mercury: Mercury sphygmomanometers account for 13% of the global market share, with approximately 19 million units in active use globally. These devices are primarily used in long-established hospitals and teaching institutes, where clinical accuracy is crucial. In 2024, 1.3 million new mercury devices were installed, mainly in regions where traditional methods are preferred. However, environmental regulations have restricted their widespread use in developed countries.

Mercury devices hold a market size of USD 704.5 million in 2025, representing 20% of the market share and a CAGR of 4.5%, with demand sustained because of their precise readings that continue to be relied upon in hospitals, research laboratories, and medical teaching institutions despite global moves away from mercury-based devices.

Top 5 Major Dominant Countries in the Mercury Segment

• United States: The United States market, with a size of USD 160 million, a 22.7% share, and a CAGR of 4.2%, is primarily driven by demand from hospital departments and research institutions where high accuracy is essential for advanced diagnostic procedures and clinical studies.
• Germany: Germany accounts for USD 82 million in market size, an 11.6% share, and a CAGR of 4.3%, largely supported by medical training institutes and specialized hospital facilities that continue to rely on mercury-based instruments for calibration and precision.
• Japan: Japan stands at USD 75 million in size, with a 10.6% share and a CAGR of 4.4%, showing consistent use of mercury sphygmomanometers within controlled hospital environments where exact measurements are prioritized for medical accuracy.
• India: India records USD 68 million in size, 9.7% market share, and a CAGR of 5.1%, driven by rural hospitals and medical colleges that continue to prefer mercury systems for reliability, especially in regions with limited access to advanced electronic systems.
• United Kingdom: The United Kingdom, with USD 61 million in market size, an 8.7% share, and a CAGR of 4.0%, maintains niche use of mercury devices in certain specialized departments where precision and teaching requirements still support their usage.

Aneroid: Aneroid sphygmomanometers hold 23% of market share, with 34 million units active worldwide. These devices are common in medium-sized clinics and outpatient care facilities, which accounted for 36% of total usage in 2024. In 2024, 3.1 million new aneroid devices were installed, particularly in Asia-Pacific and European markets. Aneroid devices are valued for portability and cost-effectiveness, which makes them suitable for field health workers and mobile clinics.

Aneroid devices will have a market size of USD 1056.7 million in 2025, capturing 30% of the global market with a CAGR of 6.0%, as these devices are widely favored for their affordability, portable design, and their ability to provide dependable manual readings in smaller clinics and healthcare facilities without mercury-related concerns.

Top 5 Major Dominant Countries in the Aneroid Segment

• United States: The United States dominates this segment with USD 280 million market size, 26.5% share, and CAGR of 6.1%, largely due to their extensive adoption in physician offices, outpatient centers, and community health facilities where portability and accuracy are essential.
• China: China represents USD 195 million in size, 18.4% share, and a CAGR of 6.7%, reflecting a growing reliance on cost-effective aneroid systems in local community medical services, government health initiatives, and rural healthcare networks.
• Germany: Germany accounts for USD 120 million in market size, 11.4% share, and a CAGR of 5.7%, supported by steady demand from private practices and general clinics where manually operated blood pressure monitoring is a routine part of primary care.
• Japan: Japan holds USD 115 million in market size, 10.9% share, and a CAGR of 5.8%, as both home users and clinical practitioners value the use of traditional manual devices that are easy to operate and maintain.
• Brazil: Brazil captures USD 95 million in market size, 9.0% share, and a CAGR of 6.8%, with growing market adoption due to the rapid expansion of healthcare services and awareness programs in both urban and rural areas..

Digital: Digital sphygmomanometers dominate with 64% share, amounting to 93 million active units worldwide. These devices are prevalent in 68% of hospitals and 58% of home healthcare environments. During 2024, 7.6 million new digital devices were installed globally. Approximately 15% of these devices integrate wireless data transfer, and 11% come with mobile app monitoring support. Digital devices are highly automated, reducing manual processes and enabling patient self-monitoring. In developed countries, 78% of newly installed devices in hospitals are digital due to their superior data recording capabilities.

Digital sphygmomanometers dominate with a market size of USD 1761.1 million in 2025, achieving 50% market share and a CAGR of 11.2%, driven by a surge in demand for advanced, easy-to-use devices integrated with mobile applications and wireless connectivity, making them ideal for home monitoring and modern healthcare systems.

Top 5 Major Dominant Countries in the Digital Segment

• United States: The United States leads with USD 600 million market size, 34% market share, and a CAGR of 11.0%, supported by strong consumer preference for home-based monitoring, integration with telemedicine, and high availability of connected health solutions.
• China: China accounts for USD 480 million in size, 27% share, and a CAGR of 12.1%, as rapid urbanization, rising incomes, and affordable digital solutions drive a surge in adoption both in urban homes and in clinics.
• Japan: Japan records USD 220 million in market size, 12.5% share, and a CAGR of 10.8%, with high demand for technologically advanced monitoring solutions that cater to an aging population and modern lifestyle needs.
• India: India posts USD 180 million in size, 10.2% share, and a CAGR of 12.5%, fueled by growing awareness, strong government support for digital health initiatives, and the increasing popularity of self-care devices.
• Germany: Germany achieves USD 150 million in market size, 8.5% share, and a CAGR of 10.5%, as healthcare facilities and households increasingly transition to automated and connected digital sphygmomanometers for accurate, easy-to-access results.

BY APPLICATION

Hospital: Hospitals are the largest end-users, with 51% of the total market share accounting for 74 million active devices worldwide. In 2024 alone, hospitals installed 6.1 million new sphygmomanometers, 72% of which were digital. These institutions require reliable and high-performance monitoring systems due to the volume of patients. In North America, hospitals use 23 million devices, while Europe accounts for 18 million and Asia-Pacific for 20 million.

Hospitals remain the largest application area with a market size of USD 1585 million in 2025, representing 45% market share and a CAGR of 7.5%, driven by the high demand for accurate and frequent blood pressure monitoring in inpatient settings, operating rooms, and intensive care units.

Top 5 Major Dominant Countries in the Hospital Application

• United States: The United States leads this segment with a market size of USD 420 million, 26.5% share, and a CAGR of 7.2%, supported by advanced medical infrastructure and strong adoption of both digital and manual devices in hospitals.
• China: China records a market size of USD 340 million, 21.5% share, and a CAGR of 8.1%, as hospital expansions and rising patient volumes continue to boost demand for high-quality monitoring devices.
• Germany: Germany accounts for USD 180 million, 11.3% share, and a CAGR of 7.3%, reflecting stable hospital infrastructure with consistent replacement demand for modern and traditional devices.
• India: India stands at USD 165 million, 10.4% share, and a CAGR of 8.3%, driven by a fast-growing hospital network, government initiatives, and rising health awareness.
• Japan: Japan posts USD 150 million in market size, 9.5% share, and a CAGR of 7.5%, as advanced hospital facilities focus on quality monitoring for an aging population.

Clinic: Clinics hold 36% share, with 53 million active sphygmomanometers in 2024. The Sphygmomanometer Market Insights show that 63% of clinics have transitioned to digital devices. In 2024, clinics installed 4.3 million new devices, with 55% being digital models. Aneroid devices remain important due to their affordability and ease of use, especially in small- and mid-sized clinics. Clinics in rural regions prefer manual or aneroid models, accounting for 40% of their installations.

Clinics form the second-largest segment with a market size of USD 1232 million in 2025, capturing 35% share and a CAGR of 8.1%, as the number of outpatient and primary care facilities grows rapidly, increasing the need for accurate and portable monitoring equipment.

Top 5 Major Dominant Countries in the Clinic Application

• United States: The United States contributes USD 300 million, 24.3% share, and a CAGR of 8.0%, with extensive adoption of manual and digital devices in primary healthcare centers and physician clinics.
• Germany: Germany stands at USD 150 million in size, 12.1% share, and a CAGR of 7.8%, as general practitioners and small clinics emphasize high-quality monitoring tools.
• China: China records USD 200 million, 16.2% share, and a CAGR of 8.6%, due to growing numbers of private clinics and urban outpatient centers.
• Brazil: Brazil holds USD 130 million in market size, 10.5% share, and a CAGR of 8.4%, supported by healthcare improvements and diagnostic expansions across cities and towns.
• India: India posts USD 120 million, 9.7% share, and a CAGR of 9.0%, driven by the rapid rise of diagnostic and specialty clinics nationwide.

Other: Other applications include home healthcare, research centers, and educational institutions, accounting for 13% share and 19 million units worldwide. In 2024, 1.6 million new devices were deployed in these applications, with 75% being digital. The growing preference for self-monitoring has expanded this segment, supported by innovations such as compact, portable monitors that integrate wireless technology. Home healthcare now represents 13% of the global market share, up from 10% in 2021, demonstrating rapid growth.

The “Others” segment, which includes homecare, emergency response, and remote monitoring, has a market size of USD 705 million in 2025, holding 20% market share and a CAGR of 10.5%, propelled by the rise in self-monitoring practices, telemedicine adoption, and portable device accessibility.

Top 5 Major Dominant Countries in the Other Applications

• United States: The United States dominates with a market size of USD 180 million, 25.5% share, and a CAGR of 10.7%, thanks to the rapid growth of telehealth services and strong consumer preference for personal home-use devices.
• Japan: Japan records USD 100 million in size, 14.1% share, and a CAGR of 10.3%, supported by its aging population and the strong cultural shift towards health tracking and home monitoring.
• India: India achieves USD 90 million, 12.8% share, and a CAGR of 11.0%, as digital health technologies, self-care, and remote consultations become popular even in semi-urban areas.
• Germany: Germany shows USD 85 million, 12% share, and a CAGR of 10.0%, with increasing adoption of wellness and home-use monitoring solutions.
• China: China posts USD 80 million, 11.3% share, and a CAGR of 11.2%, driven by robust growth in connected health ecosystems and health-conscious younger populations.

Regional Outlook for the Sphygmomanometer Market

The Sphygmomanometer Market Regional Outlook section focuses on the performance of the market across North America, Europe, Asia-Pacific, and Middle East & Africa, analyzing 39%, 28%, 25%, and 8% regional market shares, respectively. It emphasizes that North America has 57 million devices installed, Europe 41 million, Asia-Pacific 36 million, and Middle East & Africa 12 million.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates with 39% market share and 57 million active devices, including 24 million units in the United States, 6 million in Canada, and 3 million in Mexico. Digital sphygmomanometers represent 70% of the total units in North America, with aneroid devices accounting for 20% and mercury types 10%. Hospitals account for 56% of usage, clinics for 32%, and home healthcare for 12%.

North America is projected to achieve a market size of USD 1410 million in 2025, with a 40% market share and a CAGR of 8.2%, as the region benefits from advanced healthcare infrastructure, high consumer awareness, and the strong adoption of innovative digital and connected sphygmomanometer devices in hospitals, clinics, and households.

North America - Major Dominant Countries

• United States: The United States dominates this region with a market size of USD 1050 million, 74% share, and a CAGR of 8.4%, driven by significant investments in technology-driven healthcare, growing preference for home-use digital devices, and large-scale hospital networks.
• Canada: Canada accounts for USD 180 million in market size, 12.8% share, and a CAGR of 8.0%, supported by expanding clinic networks and growing emphasis on remote and home-based blood pressure monitoring solutions.
• Mexico: Mexico stands at USD 120 million, 8.5% share, and a CAGR of 7.9%, where modernization of healthcare facilities and government healthcare initiatives are boosting adoption of manual and digital devices.
• Puerto Rico: Puerto Rico records USD 30 million in market size, 2.1% share, and a CAGR of 7.5%, with rising investments in hospital diagnostic equipment and greater awareness of hypertension management.
• Costa Rica: Costa Rica, with USD 20 million in market size, 1.4% share, and a CAGR of 7.2%, benefits from improved healthcare infrastructure and the rising use of monitoring devices for both clinical and homecare purposes.

EUROPE

Europe holds 28% share, representing 41 million devices, including 10 million in Germany, 8 million in France, 7 million in the United Kingdom, 6 million in Italy, and 4 million in Spain. Digital devices account for 61% of European installations, aneroid for 26%, and mercury for 13%. In 2024, the region installed 3.4 million new units, including 2.1 million digital units. Clinics represent 38% of installations, hospitals 50%, and others 12%.

Europe is expected to reach a market size of USD 950 million in 2025, representing a 27% share and a CAGR of 7.5%, due to its well-established healthcare infrastructure, high professional standards, and an increasing preference for accurate manual devices alongside rapid adoption of advanced digital technologies across medical practices and households.

Europe - Major Dominant Countries

• Germany: Germany leads Europe with a market size of USD 250 million, 26.3% share, and a CAGR of 7.3%, as both hospitals and home users consistently prefer reliable and accurate monitoring solutions.
• United Kingdom: The United Kingdom accounts for USD 200 million in market size, 21% share, and a CAGR of 7.4%, driven by the strong growth of outpatient care systems and a growing emphasis on self-monitoring.
• France: France records USD 160 million in size, 16.8% share, and a CAGR of 7.2%, as advanced healthcare systems and rising health awareness push for both manual and digital device usage.
• Italy: Italy posts USD 140 million in size, 14.7% share, and a CAGR of 7.1%, as public and private healthcare sectors show a balanced demand for portable and home-use sphygmomanometers.
• Spain: Spain maintains USD 120 million in market size, 12.6% share, and a CAGR of 7.0%, with a consistent rise in the use of digital blood pressure devices in home settings and primary healthcare centers.

ASIA-PACIFIC

Asia-Pacific accounts for 25% share, totaling 36 million active devices, led by 11 million in China, 6 million in India, 5 million in Japan, 3 million in Australia, and 2 million in South Korea. Digital devices comprise 57% of regional installations, aneroid 29%, and mercury 14%. The region installed 3.1 million new units in 2024. Hospitals hold 48% of regional usage, clinics 40%, and others 12%.

Asia is projected to be the fastest-growing region with a market size of USD 805 million in 2025, capturing 23% share and a CAGR of 10.2%, fueled by rising population, a surge in hypertension cases, growing urbanization, increasing investments in healthcare infrastructure, and strong consumer preference for affordable and advanced blood pressure monitoring devices.

Asia - Major Dominant Countries

• China: China dominates the region with a market size of USD 300 million, 37.2% share, and a CAGR of 10.8%, driven by rapidly improving healthcare facilities, large patient base, and the rising use of digital home-based solutions.
• Japan: Japan accounts for USD 220 million, 27.3% share, and a CAGR of 9.9%, as its aging population and healthcare innovations encourage the adoption of advanced sphygmomanometers.
• India: India records USD 180 million in market size, 22.4% share, and a CAGR of 11.2%, reflecting growing awareness, healthcare reforms, and rising usage of digital homecare monitoring devices.
• South Korea: South Korea posts USD 55 million in market size, 6.8% share, and a CAGR of 10.1%, supported by strong telemedicine adoption and high technology penetration in urban centers.
• Indonesia: Indonesia reaches USD 50 million, 6.2% share, and a CAGR of 10.5%, with expanding healthcare infrastructure and growing awareness of preventive health practices.

MIDDLE EAST & AFRICA

Middle East & Africa contribute 8% market share, with 12 million active devices, including 3 million in Saudi Arabia, 2 million in UAE, 2 million in South Africa, 1.5 million in Egypt, and 1 million in Nigeria. Digital devices account for 45%, aneroid for 33%, and mercury for 22%. The region installed 1.3 million new units in 2024, including 0.7 million digital devices. Hospitals dominate with 52% usage, clinics 34%, and other uses 14%.

The Middle East and Africa region is forecast to reach a market size of USD 357 million in 2025, with a 10% market share and a CAGR of 7.8%, as healthcare infrastructure improves, awareness campaigns increase, and both manual and digital devices gain steady demand in hospitals and primary care facilities.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: Saudi Arabia leads with a market size of USD 95 million, 26.6% share, and a CAGR of 7.9%, due to increasing healthcare expenditure and modernization of hospital facilities.
• United Arab Emirates: The UAE records USD 80 million, 22.4% share, and a CAGR of 8.0%, as advanced medical centers and high-income populations drive adoption of digital and portable devices.
• South Africa: South Africa stands at USD 70 million in market size, 19.6% share, and a CAGR of 7.7%, with an improving healthcare sector and greater awareness of lifestyle diseases.
• Egypt: Egypt accounts for USD 60 million in size, 16.8% share, and a CAGR of 7.8%, fueled by ongoing health campaigns and expansion of primary care facilities.
• Nigeria: Nigeria posts USD 52 million in size, 14.6% share, and a CAGR of 7.5%, where growing urban healthcare access and public health programs encourage adoption of basic monitoring devices.

List of Top Sphygmomanometer Companies

• Promed Group
• Geratherm
• ERKA
• Visiomed
• Beurer
• Bosch + Sohn
• Isansys Lifecare
• Suzuken Company
• Lanaform
• Riester
• Hannox
• Abbott
• Troge Medical
• Withings

Abbott: Holds 18% global share, with over 26 million units installed worldwide.

Bosch + Sohn: Holds 14% share, with 20 million devices in use globally.

Investment Analysis and Opportunities

The Sphygmomanometer Market Insights show that 12 million new units were installed in 2024 alone, reflecting strong investment. Hospitals and clinics combined installed 10.4 million units, while home healthcare accounted for 1.6 million units. Wireless-enabled and app-integrated devices accounted for 15% of total new installations. Manufacturers are focusing on portable BP monitoring systems, with 26% of investments targeting direct-to-consumer models. Educational institutions and research centers have adopted 300,000 new devices for academic and clinical studies. Asia-Pacific, with 36 million total installations, remains a hotspot for new investments due to rapid healthcare infrastructure growth.

New Product Development

Between 2023 and 2025, over 1 million smart BP devices have been launched. New models feature Bluetooth connectivity, app support, and real-time data analytics. Approximately 18% of new digital models include artificial intelligence algorithms. Compact designs and battery-powered digital devices accounted for 2.2 million new units introduced in 2024. Sustainability has become a key focus, with 60% of new devices manufactured using recyclable materials.

Five Recent Developments

• 12 million sphygmomanometers installed globally in 2024.
• 8 million wireless-enabled devices introduced in 2024.
• Integration of AI-driven features in 18% of digital models.
• 70,000 healthcare facilities upgraded their monitoring systems.
• 15% of new devices include app-based patient tracking systems.

Report Coverage of Sphygmomanometer Market

The Sphygmomanometer Market Report provides detailed data from 2020 to 2025, segmented by type (digital, aneroid, mercury), application (hospital, clinic, other), and region. It highlights 146 million active devices globally, 51% hospital usage, 36% clinics, and 13% other applications. The report analyzes 64% digital device dominance, the global installation of 12 million new units in 2024, and 39% North America leadership.

Sphygmomanometer Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3828.79 Million in 2026
Market Size Value By	USD 8114.75 Million by 2035
Growth Rate	CAGR of 8.7% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Mercury Aneroid Digital By Application : Hospital Clinic Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample